Identification of rat OX40 ligand by molecular cloning

被引:21
|
作者
Akiba, H
Atsuta, M
Yagita, H
Okumura, K
机构
[1] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Japan Sci & Technol Corp, CREST, Chiyoda Ku, Tokyo 1010062, Japan
关键词
D O I
10.1006/bbrc.1998.9376
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
OX40 (CD134) is a member of the tumor necrosis factor (TNF) receptor superfamily first identified as a rat T cell activation marker. In the present study, we identified the rat Ligand for OX40 (OX40L) by molecular cloning. Rat OX40L cDNA was cloned from a HTLV-1-transformed rat T cell line by cross-hybridization with mouse OX40L cDNA. The predicted rat OX40L polypeptide is composed of 199 amino acids, showing 80.9 and 43.3% homology to mouse and human OX40L, respectively. Expression of rat OX40L mRNA was found in HTLV-1-transformed rat T cell lines. Expression of OX40L on the cell surface of these HTLV-1-transformed rat T cell lines was also demonstrated by flow cytometric analysis with a soluble fusion protein composed of the extracellular region of the Fc portion of human IgG (OX40-Ig). To explore the function of rat OX40L, we generated cDNA transfectants stably expressing rat OX40L. The rat OX40L transfectants exhibited a potent costimulatory activity for proliferation and IL-2 production of anti-CD3-stimulated rat T cells. These results indicated that rat OX40L can provide an efficient costimulation for rat T cells and that it may be involved in HTLV-1-associated pathologies in the rat system as has been suggested in the human system. (C) 1998 Academic Press.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 50 条
  • [21] OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity
    Ilves, T.
    Harvima, I. T.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (02) : E197 - E205
  • [22] Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions
    Pakala, SV
    Bansal-Pakala, P
    Halteman, BS
    Croft, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (11) : 3039 - 3046
  • [23] In Situ Reprogramming of Tumors for Activating the OX40/OX40 Ligand Checkpoint Pathway and Boosting Antitumor Immunity
    Gao, Yuxi
    Zhao, Jiayu
    Huang, Zichao
    Zhao, Hanqin
    Guo, Zhaopei
    Ma, Sheng
    Tang, Xing
    Song, Wantong
    Chen, Xuesi
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2022, 9 (07) : 4108 - 4116
  • [24] High Serum OX40 and OX40 Ligand (OX40L) Levels Correlate with Reduced Survival in Patients with Advanced Lung Adenocarcinoma
    Kashima, Jumpei
    Okuma, Yusuke
    Hosomi, Yukio
    Hishima, Tsunekazu
    ONCOLOGY, 2020, 98 (05) : 303 - 310
  • [25] Association of immune thrombocytopenia and the expression of OX40 gene and OX40 ligand in Egyptian patients with illustrating the clinical significance
    Mahmoud, Sarah
    Sayed, Doaa S. S.
    Mohamed, Seham O.
    Hammam, Amira A.
    Morga, Dalia S.
    Elgendy, Sara O.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2024, 49 (03): : 318 - 324
  • [26] OX40/OX40 ligand interaction is critical for chronic intestinal inflammation in DSS-induced colitis in mice.
    Obermeier, F
    Schwarz, H
    Dunger, N
    Schölmerich, J
    Falk, W
    GASTROENTEROLOGY, 2002, 122 (04) : A390 - A390
  • [27] Blockade of OX40/OX40 Ligand to Decrease Cytokine messenger RNA Expression in Acute Renal Allograft Rejection In Vitro
    Wang, Y-L
    Li, G.
    Fu, Y-X.
    Wang, H.
    Shen, Z-Y
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (06) : 2565 - 2568
  • [28] OX40 inhibition
    Coburn, Cassandra
    LANCET ONCOLOGY, 2016, 17 (06): : 707 - 708
  • [29] Expression and function of OX40 ligand on human dendritic cells
    Ohshima, Y
    Tanaka, Y
    Tozawa, H
    Takahashi, Y
    Maliszewski, C
    Delespesse, G
    JOURNAL OF IMMUNOLOGY, 1997, 159 (08): : 3838 - 3848
  • [30] OX40 ligand: a potential costimulatory molecule in atopic asthma
    Farres, Mohamed Nazmy
    Sabry, Mohamed Kamel
    Ahmed, Eman Elsayed
    Elkady, Hossam Moustafa
    Mohamed, Nesrine Aly
    JOURNAL OF ASTHMA, 2014, 51 (06) : 573 - 577